Pain Self-Efficacy (PSEQ) score of <22 is associated with daily opioid use, back pain, disability, and PROMIS scores in patients presenting for spine surgery.

Autor: Mo KC; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA., Gupta A; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA., Movsik J; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA., Covarrubius O; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA., Greenberg M; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA., Riley LH 3rd; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA., Kebaish KM; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA., Neuman BJ; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA., Skolasky RL; Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA. Electronic address: rskolas1@jhmi.edu.
Jazyk: angličtina
Zdroj: The spine journal : official journal of the North American Spine Society [Spine J] 2023 May; Vol. 23 (5), pp. 723-730.
DOI: 10.1016/j.spinee.2022.12.015
Abstrakt: Background Context: Pain self-efficacy, or the belief that one can carry out activities despite pain, has been shown to be associated with back and neck pain severity. However, the literature correlating psychosocial factors to opioid use, barriers to proper opioid use, and Patient-Reported Outcome Measurement Information System (PROMIS) scores is sparse.
Purpose: The primary aim of this study was to determine whether pain self-efficacy is associated with daily opioid use in patients presenting for spine surgery. The secondary aim was to determine whether there exists a threshold self-efficacy score that is predictive of daily preoperative opioid use and subsequently to correlate this threshold score with opioid beliefs, disability, resilience, patient activation, and PROMIS scores.
Patient Sample: Five hundred seventy-eight elective spine surgery patients (286 females; mean age of 55 years) from a single institution were included in this study.
Study Design/setting: Retrospective review of prospectively collected data.
Outcome Measures: PROMIS scores, daily opioid use, opioid beliefs, disability, patient activation, resilience.
Methods: Elective spine surgery patients at a single institution completed questionnaires preoperatively. Pain self-efficacy was measured by the Pain Self-Efficacy Questionnaire (PSEQ). Threshold linear regression with Bayesian information criteria was utilized to identify the optimal threshold associated with daily opioid use. Multivariable analysis controlled for age, sex, education, income, and Oswestry Disability Index (ODI) and PROMIS-29, version 2 scores.
Results: Of 578 patients, 100 (17.3%) reported daily opioid use. Threshold regression identified a PSEQ cutoff score of <22 as predictive of daily opioid use. On multivariable logistic regression, patients with a PSEQ score <22 had two times greater odds of being daily opioid users than those with a score ≥22. Further, PSEQ <22 was associated with lower patient activation; increased leg and back pain; higher ODI; higher PROMIS pain, fatigue, depression, and sleep scores; and lower PROMIS physical function and social satisfaction scores (p<.05 for all).
Conclusions: In patients presenting for elective spine surgery, a PSEQ score of <22 is associated with twice the odds of reporting daily opioid use. Further, this threshold is associated with greater pain, disability, fatigue, and depression. A PSEQ score <22 can identify patients at high risk for daily opioid use and can guide targeted rehabilitation to optimize postoperative quality of life.
Competing Interests: Declaration of competing interests One or more of the authors declare financial or professional relationships on ICMJE-TSJ disclosure forms.
(Copyright © 2022 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: